Please enable JavaScript to continue.
When beginning GLP-1 medications, the potential benefits of weight loss and overall improvement of your health can be very exciting
( A ) Intracellular accumulation of cAMP was measured by enzymatic immunoassay in lysates from caSMCs treated for 10 minutes with 100 nM each of GLP-1, forskolin, or PBS control, with or without 20 M sacubitril, a neutral endopeptidase inhibitor ( n = 3/treatment, each in triplicate)
Demonstrating the efficacy of NAC in this model allows for a specific understanding of the utility of such treatments in the context of increased oxidative stress in many neurological diseases
Harada M, Suzuki M, Ikeda T, Kaneko T, Harada S, Fukayama M